ICON Announces The Appointment Of Dr. Steve Cutler To Board Of Directors
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr. Steve Cutler to the ICON Board of Directors.
Dr. Cutler joined ICON in 2011 as Group President, ICON Clinical Research Services. Dr. Cutler successfully led this business to significant growth and, as a result, was promoted to Chief Operating Officer in January 2014.
Dr. Cutler joined ICON in 2011 as Group President, ICON Clinical Research Services. Dr. Cutler successfully led this business to significant growth and, as a result, was promoted to Chief Operating Officer in January 2014.